These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
767 related articles for article (PubMed ID: 25102234)
1. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234 [TBL] [Abstract][Full Text] [Related]
2. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance. Zhao D; Zhang H; Yang S; He W; Luan Y Int J Pharm; 2016 Dec; 515(1-2):281-292. PubMed ID: 27746331 [TBL] [Abstract][Full Text] [Related]
3. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery. Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751 [TBL] [Abstract][Full Text] [Related]
4. Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers. Chen FQ; Zhang JM; Fang XF; Yu H; Liu YL; Li H; Wang YT; Chen MW Acta Pharmacol Sin; 2017 Jun; 38(6):859-873. PubMed ID: 28260803 [TBL] [Abstract][Full Text] [Related]
5. Adding vitamin E-TPGS to the formulation of Genexol-PM: specially mixed micelles improve drug-loading ability and cytotoxicity against multidrug-resistant tumors significantly. Fan Z; Chen C; Pang X; Yu Z; Qi Y; Chen X; Liang H; Fang X; Sha X PLoS One; 2015; 10(4):e0120129. PubMed ID: 25831130 [TBL] [Abstract][Full Text] [Related]
6. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance. Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018 [TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537 [TBL] [Abstract][Full Text] [Related]
8. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552 [TBL] [Abstract][Full Text] [Related]
9. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
10. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution. Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562 [TBL] [Abstract][Full Text] [Related]
11. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
12. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy. Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433 [TBL] [Abstract][Full Text] [Related]
13. A personalized and long-acting local therapeutic platform combining photothermal therapy and chemotherapy for the treatment of multidrug-resistant colon tumor. Wang B; Wu S; Lin Z; Jiang Y; Chen Y; Chen ZS; Yang X; Gao W Int J Nanomedicine; 2018; 13():8411-8427. PubMed ID: 30587968 [TBL] [Abstract][Full Text] [Related]
14. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253 [TBL] [Abstract][Full Text] [Related]
15. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance. Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367 [TBL] [Abstract][Full Text] [Related]
16. pH-sensitive docetaxel-loaded D-α-tocopheryl polyethylene glycol succinate-poly(β-amino ester) copolymer nanoparticles for overcoming multidrug resistance. Zhao S; Tan S; Guo Y; Huang J; Chu M; Liu H; Zhang Z Biomacromolecules; 2013 Aug; 14(8):2636-46. PubMed ID: 23815156 [TBL] [Abstract][Full Text] [Related]
17. Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors. Wang AT; Liang DS; Liu YJ; Qi XR Biomaterials; 2015 Jun; 53():160-72. PubMed ID: 25890716 [TBL] [Abstract][Full Text] [Related]
18. Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer. Ma Y; Liu D; Wang D; Wang Y; Fu Q; Fallon JK; Yang X; He Z; Liu F Mol Pharm; 2014 Aug; 11(8):2623-30. PubMed ID: 24712391 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance. Jin X; Mo R; Ding Y; Zheng W; Zhang C Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of TPGS-modified thermo-sensitive Pluronic PF127 hydrogel as a potential carrier to reverse the resistance of P-gp-overexpressing SMMC-7721 cell lines. Gao L; Wang X; Ma J; Hao D; Wei P; Zhou L; Liu G Colloids Surf B Biointerfaces; 2016 Apr; 140():307-316. PubMed ID: 26764117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]